Literature DB >> 30776063

Heritability of Cerebral Blood Flow and the Correlation to Schizophrenia Spectrum Disorders: A Pseudo-continuous Arterial Spin Labeling Twin Study.

Christian S Legind1,2,3, Brian V Broberg1,2, Rachel Brouwer4, René C W Mandl1,2,4, Bjørn H Ebdrup1,2,3, Simon J Anhøj1,2, Maria H Jensen1,2, Rikke Hilker1,2, Birgitte Fagerlund1,2,5, Hilleke E Hulshoff Pol4, Birte Y Glenthøj1,2,3, Egill Rostrup1,2,6.   

Abstract

Whether aberrant cerebral blood flow (CBF) in schizophrenia is affected by genetic influences, and consequently a potential marker for genetic susceptibility, is unknown. Our aims were to determine the heritability of CBF in thalamic, frontal, and striatal areas, and to ascertain if associations with disease were under genetic influence. Monozygotic (MZ) twin pairs concordant (n = 2) or discordant (n = 20) for schizophrenia spectrum disorders (ICD-10 F2x.x), matched on sex and age with dizygotic (DZ; n = 20) and healthy control pairs (MZ: n = 27; DZ: n = 18; total: n = 181 individuals), were recruited via the National Danish Twin Register. CBF in thalamus, frontal lobes, and putamen was measured with pseudo-continuous arterial spin labeling on a 3 T magnetic resonance scanner. Twin statistics were performed with structural equation modeling. CBF in the frontal lobes was heritable (h2 = 0.44, 95% CI [0.22-0.60]) but not correlated to disease. CBF correlated to schizophrenia spectrum disorders in the left thalamus (r = 0.17, [0.03-0.31]; P = 0.02), as well as in the left putamen (r = 0.19, [0.05-0.32]; P = 0.007) and the right putamen (r = 0.18, [0.03-0.32]; P = 0.02). When restricting the sample to schizophrenia (F20.x) only, shared genetic influences between CBF in the left putamen and schizophrenia liability (phenotypic correlation = 0.44, [0.28-0.58], P < 0.001) were found. Our results provide heritability estimates of CBF in the frontal lobes, and we find CBF in thalamus and putamen to be altered in schizophrenia spectrum disorders. Furthermore, shared genetic factors influence schizophrenia liability and striatal perfusion. Specifically, higher perfusion in the left putamen may constitute a marker of genetic susceptibility for schizophrenia.
© The Author(s) 2019. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  cerebral blood flow; genes; pCASL; relatives; twins

Year:  2019        PMID: 30776063      PMCID: PMC6811820          DOI: 10.1093/schbul/sbz007

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  48 in total

1.  Effect of antipsychotics on regional cerebral blood flow measured with positron emission tomography.

Authors:  D D Miller; N C Andreasen; D S O'Leary; K Rezai; G L Watkins; L L Ponto; R D Hichwa
Journal:  Neuropsychopharmacology       Date:  1997-10       Impact factor: 7.853

2.  Regional neural dysfunctions in chronic schizophrenia studied with positron emission tomography.

Authors:  J J Kim; S Mohamed; N C Andreasen; D S O'Leary; G L Watkins; L L Boles Ponto; R D Hichwa
Journal:  Am J Psychiatry       Date:  2000-04       Impact factor: 18.112

3.  Hypofrontality in schizophrenia: distributed dysfunctional circuits in neuroleptic-naïve patients.

Authors:  N C Andreasen; D S O'Leary; M Flaum; P Nopoulos; G L Watkins; L L Boles Ponto; R D Hichwa
Journal:  Lancet       Date:  1997-06-14       Impact factor: 79.321

Review 4.  Speculation on the meaning of cerebral metabolic hypofrontality in schizophrenia.

Authors:  D R Weinberger; K F Berman
Journal:  Schizophr Bull       Date:  1988       Impact factor: 9.306

5.  Static and dynamic characteristics of cerebral blood flow during the resting state in schizophrenia.

Authors:  Jochen Kindler; Kay Jann; Philipp Homan; Martinus Hauf; Sebastian Walther; Werner Strik; Thomas Dierks; Daniela Hubl
Journal:  Schizophr Bull       Date:  2013-12-10       Impact factor: 9.306

Review 6.  Positron emission tomography studies of abnormal glucose metabolism in schizophrenia.

Authors:  M S Buchsbaum; E A Hazlett
Journal:  Schizophr Bull       Date:  1998       Impact factor: 9.306

7.  OpenMx: An Open Source Extended Structural Equation Modeling Framework.

Authors:  Steven Boker; Michael Neale; Hermine Maes; Michael Wilde; Michael Spiegel; Timothy Brick; Jeffrey Spies; Ryne Estabrook; Sarah Kenny; Timothy Bates; Paras Mehta; John Fox
Journal:  Psychometrika       Date:  2011-04-01       Impact factor: 2.500

8.  Hypofrontality in schizophrenia: a meta-analysis of functional imaging studies.

Authors:  K Hill; L Mann; K R Laws; C M E Stephenson; I Nimmo-Smith; P J McKenna
Journal:  Acta Psychiatr Scand       Date:  2004-10       Impact factor: 6.392

Review 9.  Perfusion magnetic resonance imaging in psychiatry.

Authors:  Jean Théberge
Journal:  Top Magn Reson Imaging       Date:  2008-04

10.  Modulation of limbic circuitry predicts treatment response to antipsychotic medication: a functional imaging study in schizophrenia.

Authors:  Adrienne C Lahti; Martin A Weiler; Henry H Holcomb; Carol A Tamminga; Karen L Cropsey
Journal:  Neuropsychopharmacology       Date:  2009-08-12       Impact factor: 7.853

View more
  2 in total

1.  Add-On MEmaNtine to Dopamine Antagonism to Improve Negative Symptoms at First Psychosis- the AMEND Trial Protocol.

Authors:  Katharina O Sandström; Olga B Baltzersen; Anouk Marsman; Cecilie K Lemvigh; Vincent O Boer; Kirsten B Bojesen; Mette Ø Nielsen; Henrik Lundell; Daban K Sulaiman; Mikkel E Sørensen; Birgitte Fagerlund; Adrienne C Lahti; Warda T Syeda; Christos Pantelis; Esben T Petersen; Birte Y Glenthøj; Hartwig R Siebner; Bjørn H Ebdrup
Journal:  Front Psychiatry       Date:  2022-05-20       Impact factor: 5.435

2.  Brain features of nearly drug-naïve female monozygotic twins with first-episode schizophrenia and the classification accuracy of brain feature patterns: A pilot study.

Authors:  Tao Zhang; Jie Song; Ce Chen; Ran Li; Yachen Li; Yun Sun; Tao Fang; Weiwei Xu; Hongjun Tian; Chuanjun Zhuo
Journal:  Brain Behav       Date:  2020-12-08       Impact factor: 3.405

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.